Literature DB >> 11734313

Analysis of the distribution and frequency of trisomy 7 in vivo in synovia from patients with osteoarthritis and pigmented villonodular synovitis.

A Dahlén1, K Broberg, H A Domanski, S Toksvig-Larsen, A Lindstrand, N Mandahl, F Mertens.   

Abstract

Osteoarthritis (OA) and pigmented villonodular synovitis (PVNS) are disorders associated with trisomy 7. The aim of the present study was to determine the frequency and distribution of the cells with +7 in vivo by analyzing sections of paraffin-embedded synovia from patients affected by OA, PVNS, other forms of synovitis [hemorragic synovitis (HS) and chronic synovitis (CS)], and from individuals without joint disease. Fluorescence in situ hybridization (FISH), using a centromeric probe for chromosome 7, showed that the mean frequency of trisomic nuclei in 5-microm sections was highest in PVNS (9.0%), followed by CS (5.9%), OA (5.6%), and HS (4.6%), whereas trisomic nuclei were rare (0.7%) in normal tissue. When 8-microm sections were studied, the frequencies of trisomic cells in OA and control synovia increased to 6.7% and 1.5%, respectively. Trisomic nuclei were found in all cases, including those for which cytogenetic analysis of short-term cultures had not disclosed any trisomic cells. Overall, the trisomic cells were scattered within the tissue. However, small clusters of cells with +7 were found in three cases. By hematoxylin-eosin staining of the slides used for FISH analysis it could be shown that the clustered trisomic cells were proliferating synoviocytes within villous extensions of the synovial membrane.

Entities:  

Mesh:

Year:  2001        PMID: 11734313     DOI: 10.1016/s0165-4608(01)00488-5

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  9 in total

1.  Genetic and environmental influences on spontaneous micronuclei frequencies in children and adults: a twin study.

Authors:  Kimberly H Jones; Timothy P York; Jane Juusola; Andrea Ferreira-Gonzalez; Hermine H Maes; Colleen Jackson-Cook
Journal:  Mutagenesis       Date:  2011-07-15       Impact factor: 3.000

Review 2.  Safety of using cultured cells with trisomy 7 in cell therapy for treating osteoarthritis.

Authors:  Mitsuru Mizuno; Nobutake Ozeki; Ichiro Sekiya
Journal:  Regen Ther       Date:  2022-06-17       Impact factor: 3.651

3.  Trisomy 7 in synovial fluid cells of patients with rheumatoid arthritis.

Authors:  Funda Tascioglu; Beyhan Durak; Cengiz Oner; Sevilhan Artan
Journal:  Rheumatol Int       Date:  2004-06-25       Impact factor: 2.631

4.  Tenosynovial giant cell tumour (pigmented villonodular synovitis-)-like changes in periprosthetic interface membranes.

Authors:  Stephan Söder; Stefan Sesselmann; Thomas Aigner; Stephan Oehler; Abbas Agaimy
Journal:  Virchows Arch       Date:  2015-11-09       Impact factor: 4.064

5.  Molecular cytogenetic characterization of tenosynovial giant cell tumors.

Authors:  Petter Brandal; Bodil Bjerkehagen; Sverre Heim
Journal:  Neoplasia       Date:  2004 Sep-Oct       Impact factor: 5.715

6.  Perceived Stress Levels, Chemotherapy, Radiation Treatment and Tumor Characteristics Are Associated with a Persistent Increased Frequency of Somatic Chromosomal Instability in Women Diagnosed with Breast Cancer: A One Year Longitudinal Study.

Authors:  Noran Aboalela; Debra Lyon; R K Elswick; Debra Lynch Kelly; Jenni Brumelle; Harry D Bear; Colleen Jackson-Cook
Journal:  PLoS One       Date:  2015-07-15       Impact factor: 3.240

Review 7.  Necessity of adjuvant postoperative radiotherapy for diffuse pigmented villonodular synovitis of the knee: A case report and literature review.

Authors:  Yanfang Duan; Jing Qian; Kun Chen; Zhuo Zhang
Journal:  Medicine (Baltimore)       Date:  2018-01       Impact factor: 1.889

8.  Update on Tenosynovial Giant Cell Tumor, an Inflammatory Arthritis With Neoplastic Features.

Authors:  Marie Robert; Helena Farese; Pierre Miossec
Journal:  Front Immunol       Date:  2022-02-21       Impact factor: 7.561

9.  Transplantation of human autologous synovial mesenchymal stem cells with trisomy 7 into the knee joint and 5 years of follow-up.

Authors:  Mitsuru Mizuno; Kentaro Endo; Hisako Katano; Naoki Amano; Masaki Nomura; Yoshinori Hasegawa; Nobutake Ozeki; Hideyuki Koga; Naoko Takasu; Osamu Ohara; Tomohiro Morio; Ichiro Sekiya
Journal:  Stem Cells Transl Med       Date:  2021-08-03       Impact factor: 6.940

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.